Immunogen, Inc.

Get Full Access

Description

  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Its preclinical program include IMGC936, an investigational ADC in co-development with MacroGenics, Inc. ImmunoGen, Inc. has collaborations with Roche; Amgen/Oxford BioTherapeutics; sanofi-aventis U. S. LLC; Biotest AG; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Takeda Pharmaceutical Company Limited; Fusion Pharmaceuticals Inc.; Debiopharm International SA; Jazz Pharmaceuticals Ireland Limited; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
  • location

    Headquarters:830 Winter Street , Waltham, Massachusetts, United States

    More
  • Immunogen, Inc. phone

    Phone Number: +1 781-895-0600

  • Immunogen, Inc. website

    Website: https://www.immunogen.com

  • Immunogen, Inc. employees

    Employees:239

  • Immunogen, Inc. revenue

    Revenue:$100 - 250M

  • Immunogen, Inc. legal name

    Legal Name:Immunogen, Inc.

  • Immunogen, Inc.'s Social Media

    Immunogen, Inc. linkedin Immunogen, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 541720  |

      NYSE: IMGN

    Show More
Person level website identification

CEO for Immunogen, Inc.

Mitch Sayare

Chairman, Chief Executive Officer At Immunogen, Inc

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Anna Berkenblit

Senior Vice President And Chief Medical Officer

Maurisa Croce

Vice President, Product Team Leader

Fred Cordero

Executive Vice President

Joseph Kenny

Vice President, Intellectual Property And Chief Patent Counsel

Robert Herbst

Vice President

Frequently Asked Questions regarding Immunogen, Inc.

  • Where are Immunogen, Inc.'s Headquarters?

    Immunogen, Inc.'s Headquarters are in 830 Winter Street ,Waltham,Massachusetts,United States

  • What is Immunogen, Inc.'s phone number?

    Immunogen, Inc.'s phone number is +1 781-895-0600

  • What is Immunogen, Inc.'s stock symbol?

    Immunogen, Inc.'s stock symbol is IMGN

  • What is Immunogen, Inc.'s official website?

    Immunogen, Inc.'s official website is https://www.immunogen.com

  • What is Immunogen, Inc.'s Revenue?

    Immunogen, Inc.'s revenue is $100 - 250M

  • What is Immunogen, Inc.'s NAICS code?

    Immunogen, Inc.'s NAICS code is 541720

  • How many employees are working in Immunogen, Inc.

    Immunogen, Inc. has 239 employees

  • What is Immunogen, Inc.'s Industry?

    Immunogen, Inc. is in the industry of Biotechnology

Company Directory